BCR and prostate cancer: In conclusion, our data revealed that three candidate piRNAs, namely, hsa_pir_000627, hsa_pir_005553 and hsa_pir_019346, had significant correlation with BCR of prostate cancer and can be potential prognostic biomarkers.